Non-invasive monitoring liver iron content (LIC) is critical for clinical management or effective therapeutic strategy of patients because the increment of iron accumulation within the liver may contribute to liver disease via the production of reactive oxygen species. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and is reported to between 10% and 30%, with similar rates reported from Europe and Asia. However, it is difficult to distinguish the sub-groups in NAFLD, especially simple steatosis (SS) and non-alcoholic steatohepatitis (NASH), unless by liver biopsy. Therefore, it is important to monitor liver iron content (LIC) in NASH patients for clinical management or effective therapeutic strategy of patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords